ライフサイエンスコーパス: sore throat

1 strains causing pharyngitis (streptococcal "sore throat").

2 with symptoms of a viral infection (cold and sore throat).

3 ing the former a more likely diagnosis for a sore throat.

4 from schoolchildren self-identifying with a sore throat.

5 included fever, cough, nasal congestion, and sore throat.

6 ics, is cultured in 5% to 17% of adults with sore throat.

7 89-1999, by adults with a chief complaint of sore throat.

8 lness with subjective fever, runny nose, and sore throat.

9 h citrus-derived pectin powder, she had mild sore throat.

10 m as part of the evaluation of patients with sore throat.

11 nage (4.0 days and 7.0 days; P < 0.001), and sore throat (1.0 day and 3.0 days; P < 0.001).

12 nasal congestion (36%), headache (30%), and sore throat (19%).

13 57%, respectively), cough (25% and 32%), and sore throat (21% and 45%); headache had low sensitivity

14 for acute upper respiratory tract illnesses (sore throat, 34.3%; ear infection, 26.2%; and colds or f

15 The first symptom noticed most often was sore throat (40%) in HRV culture- or PCR-positive patien

16 of sense of smell (41%), headache (40%), and sore throat (40%).

17 ms, including dry and itchy throat (64.16%), sore throat (59.95%), hoarseness (57.90%), nasal congest

18 ymptom (80.5%), followed by myalgia (70.7%), sore throat (63.4%), and fever (58.5%).

19 ctivated vaccine group, and coryza (12%) and sore throat (8%) were observed in the attenuated vaccine

20 The typical symptoms were sore throat (93.5%), fever (86.0%), pseudomembrane (34.7

21 adults presenting to primary care with acute sore throat, a single dose of oral dexamethasone compare

22 d the following allergic symptoms at age 11: sore throat after ingesting gummy bears containing citru

23 Increases in sore throat (also common in the general community), and

24 (ILI, defined as presence of fever and cough/sore throat) among the survey participants during period

25 r-old male patient who presented with fever, sore throat and dizziness.

26 ed value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive (range, 0.81-0.83)

27 symptoms following the procedure were cough, sore throat and fatigue.

28 55.0%; 11/20), and typical symptoms included sore throat and fever.

29 from relatively minor complications such as sore throat and hoarseness, as well as aiming to reduce

30 eptococcus (GAS), the agent of streptococcal sore throat and invasive soft tissue infections, evades

31 eptococcus, GAS), the agent of streptococcal sore throat and invasive soft-tissue infections, attache

32 dren between 2 and 13 years of age who had a sore throat and pharyngeal erythema were enrolled in the

33 uenza-like illness (fever including cough or sore throat) and all patient visits by age.

34 ociated both with pharyngitis (streptococcal sore throat) and with invasive or "flesh-eating" soft ti

35 71 (36.0%) reported rectal pain, 33 (16.8%) sore throat, and 31 (15.7%) penile oedema.

36 ure keratitis, subconjunctival hemorrhage, a sore throat, and a transient increase in neutralizing an

37 cluded hiccups, anorexia, fatigue, vomiting, sore throat, and difficulty swallowing.

38 lta versus Alpha infection (including fever, sore throat, and headache) and some vice versa (dyspnoea

39 shaking with chills, muscle pain, headache, sore throat, and new loss of taste or smell) by day 30.

40 asive disease, throat swabs of patients with sore throat, and throat swabs of asymptomatic school-age

41 Most sore throats are due to viral upper respiratory tract in

42 l visits in the United States by adults with sore throat between 1989 and 1999.

43 ibiotics reduce the risk of complications of sore throat by at least 50%, but few trials for complica

44 f of adults are treated with antibiotics for sore throat by community primary care physicians.

45 presented to our emergency room with fever, sore throat, cough and poor appetite for 2 weeks.

46 of rhinorrhea, sneezing, nasal obstruction, sore throat, cough, and headache and reduced nasal mucus

47 fluenza-like illness (ILI; fever and >/=2 of sore throat, cough, muscle ache, or headache) and colds

48 2 of runny nose, nasal congestion, sneezing, sore throat, cough, swollen or tender neck glands).

49 The primary outcome was the number of sore throat days collected during 24 months after random

50 e severity, the incident rate ratio of total sore throat days in the immediate tonsillectomy group (n

51 If patients aged 15 years or older with sore throat did not visit a clinician when the new score

52 sses with new or worsened cough, runny nose, sore throat, difficulty breathing or myalgia, and collec

53 owing: cough, rhinorrhoea, nasal congestion, sore throat, difficulty breathing, and/or abnormal chest

54 sses with new or worsened cough, runny nose, sore throat, difficulty breathing, or myalgia and collec

55 ediate tonsillectomy group had fewer days of sore throat during 24 months than those in the conservat

56 tion of hypothyroidism, higher proportion of sore throat during acute illness, higher proportions of

57 ed a case as a cadet with new onset cough or sore throat during August 1-October 4, 2019.

58 were more likely to experience runny nose or sore throat during the first 7 days after vaccination, b

59 ually present with an exudative tonsillitis, sore throat, dysphagia, and unilateral neck pain.

60 the throat, asthma-like symptoms, recurrent sore throat, frequent throat clearing, halithosis and de

61 found in 69 (26.5%) of the 260 patients with sore throat from whom group A streptococcus was isolated

62 proximately 1 in 13 patients presenting with sore throat has mononucleosis).

63 us infections, including strep throat, other sore throat, head or chest cold, influenza/pneumonia, si

64 ioprine initiation preceded admission with a sore throat, headache, myalgia, and pyrexia.

65 d severe illnesses but more likely to report sore throat, headache, myalgia, and taste or smell loss.

66 moval, and the most common side-effect was a sore throat in 63 (4%) of 1654 participants.

67 alactiae subsp. equisimilis colonization and sore throat in a study of 2,194 children of 3 to 15 year

68 ectiveness of oral corticosteroids for acute sore throat in the absence of antibiotics.

69 four of nine patients), myalgia (in three), sore throat (in two), and malaise (in two), were also ob

70 decreased after Omicron BA.1 dominated, but sore throat increased, the latter to a greater degree th

71 Sore throat is a common complaint, and identifying patie

72 f DESCARTE, of 12,829 adults presenting with sore throat (</= 2 weeks duration) in primary care.

73 Prescribing choices for sore throat may need additional explanation to ensure pa

74 to 21 March 2013, patients presenting with a sore throat meeting criteria for GAS testing and not mee

75 Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing

76 ummy bears containing citrus-derived pectin; sore throat, nausea, and severe abdominal pain after ing

77 r, prostration, headache, arthralgia, cough, sore throat, nausea, vomiting, diarrhea, epistaxis, blee

78 Nausea/vomiting or sore throat/nose occurred in 17 of the 409 children who

79 y of presentation to primary care with acute sore throat not requiring immediate antibiotic therapy.

80 ted mild symptoms (82.8% [24/29] developed a sore throat); one developed otitis media requiring antib

81 isolated from individuals with streptococcal sore throat or invasive ("flesh-eating") infection often

82 headache (OR = 3.37, 95% CI 1.18-9.60), and sore throat (OR = 3.56, 95% CI 1.21-10.46) during infect

83 t, or lungs (OR = 4.73; 95% CI: 3.10, 7.22), sore throat (OR = 4.66; 95% CI: 2.89, 7.51), dizziness (

84 myalgia, cough, runny nose/nasal congestion, sore throat, or difficulty breathing.

85 Isolated fever, cough, sore throat, or headache, but not congestion/rhinorrhea,

86 l), as coughing and/or wheezing, hoarseness, sore throat, otitis media, and dental manifestations.

87 efined here as self-reported fever and cough/sore throat, over several influenza seasons allows for e

88 P < .0001), persistent cough (P = .002), and sore throat (P < .0001) CONCLUSIONS: Rural and public te

89 Acute sore throat poses a significant burden on primary care a

90 likelihood ratio, 0.2 [CI, 0.1 to 0.4]) and sore throat (positive likelihood ratio, 0.2 [CI, 0.1 to

91 tive studies (having > or =300 patients with sore throat) reporting history and physical examination

92 of the household had a runny nose, cough, or sore throat, respectively.

93 >/=37.8 degrees C, headache, myalgia, cough, sore throat, runny nose and sputum), paucisymptomatic (1

94 Increased cough, sore throat, runny nose, and sneezing are associated wit

95 ands, and 0.37 (0.34 to 0.39, p < 0.001) for sore throat, swollen glands, and fever.

96 Sore throat, temperature >38 degrees C, and clinically a

97 dolescent and adult patients presenting with sore throat, the presence of posterior cervical, inguina

98 All offered sore throat treatment (average price, $78) and more than

99 ssfully employed in candies and lozenges for sore throat treatment.

100 reptococci (GABHS), the only common cause of sore throat warranting antibiotics, is cultured in 5% to

101 Sore throat was associated with Omicron infection (aOR,

102 Sore throat was more common during omicron prevalence th

103 ss of sense of smell was reported less while sore throat was reported more.

104 related to anthrax (including buccal ulcers-sore throat) was 7.46%.

105 and the numbers of these reporting cough and sore throat were higher than during pre-Delta and Delta

106 1.7 with wild type, new persistent cough and sore throat were more predictive of B.1.1.7 infection wh

107 psoriasis and history of exacerbation after sore throat were randomly assigned to tonsillectomy (n =

108 investigation showed that fever, cough, and sore throat were the three most common respiratory sympt

109 he first scenario described a patient with a sore throat who took unprescribed antibiotics; responden

110 The most common symptom was sore throat with fever (34% vs 34%), with a baseline mea

111 th fever, 0.47 (0.44 to 0.50, p < 0.001) for sore throat with swollen glands, and 0.37 (0.34 to 0.39,

112 of extra-aortic mycotic aneurysm following a sore throat without demonstrable bacteremia where identi